Indian stock markets saw a dramatic rally as the Sensex surged over 2,100 points, and the Nifty climbed by 553.25 points, marking a strong recovery on Monday. This was the first trading day since the India-Pakistan ceasefire agreement. Despite the tension in the region, the markets displayed impressive resilience, with investors rushing back into equities after the stabilization of the situation at the borders.
Market Recovery Amid Stable Borders
The Indian stock markets reacted positively as the uncertainty from the recent India-Pakistan conflict began to subside. The Sensex jumped 1,793.73 points, reaching 81,248.20, while the Nifty rose 553.25 points to 24,561.25. According to experts, the markets were quick to recover due to the ceasefire understanding, which helped restore investor confidence. The ongoing geopolitical tensions had weighed heavily on investor sentiment, but the stabilization brought a sense of relief.
“Indian markets weathered the turbulence quite well and are set to recover smartly today,” said Ajay Bagga, a banking and market expert. “Indian futures are pointing to a sharp 2% up-move as the losses caused by the conflict are quickly made up.” The overall market momentum was driven by strong inflows, with investors eager to take advantage of the dip caused by the conflict.
Sector-Specific Gains and Global Factors
The rally was widespread, with the Nifty Auto sector rising 2.25% and Nifty IT increasing by 2.16%. Nifty Realty emerged as the leader, surging over 4% during early trade. The favorable cues from the global market also boosted sentiment. The US and China reported positive trade talks in Geneva over the weekend, further lifting market morale.
On the commodity front, gold prices dropped by over 2%, while oil prices and the US dollar saw a rise. US futures also indicated an expected gain of over 1% for Wall Street, which helped enhance the positive sentiment across global markets.
Despite the strong rally, pharmaceutical stocks faced a setback. Indian pharmaceutical stocks fell by 1.3%, even as the broader market surged. This drop came after US President Donald Trump announced plans to sign an executive order aimed at lowering prescription drug prices. Sun Pharma, India’s largest pharmaceutical company, dropped by 5.4%, becoming the top loser on both the Nifty 50 and the pharma index. Glenmark Pharma and Cipla also saw declines of 0.4% and 1.5%, respectively.
